Nektar Therapeutics (NKTR) Misses Q4 EPS by 178c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $74.02 --0%
Financial Fact:
Income (loss) from operations: -32.9M
Today's EPS Names:
SQZB, RENO, LUNA, More
Financial Fact:
Income (loss) from operations: -32.9M
Today's EPS Names:
SQZB, RENO, LUNA, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($1.78). Revenue for the quarter came in at $21.81 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- NAPCO Security Tech (NSSC) Tops Q4 EPS by 11c
- Scinai posts H1 2026 results with wider operating loss, net gain
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
